Controversies of renin–angiotensin system inhibition during the COVID-19 pandemicAndrew M. South, Matthew A. Sparks, Laurie A. Tomlinson et al.|Nature Reviews Nephrology|2020Cited by 292
Impact of long COVID on health-related quality-of-life: an OpenSAFELY population cohort study using patient-reported outcome measures (OpenPROMPT)Oliver Carlile, Rebecca Smith, Ben F.C. Butler-Cole et al.|The Lancet Regional Health - Europe|2024Cited by 95
Kidney Function Decline After COVID-19 InfectionViyaasan Mahalingasivam, Juan Jesús Carrero, Anne‐Laure Faucon et al.|JAMA Network Open|2024Cited by 35
Healthcare utilisation in people with long COVID: an OpenSAFELY cohort studyLiang-Yu Lin, Emily Herrett, Alasdair D Henderson et al.|BMC Medicine|2024Cited by 33
Clinical coding of long COVID in primary care 2020–2023 in a cohort of 19 million adults: an OpenSAFELY analysisAlasdair D Henderson, Peter Inglesby, Ben Butler-Cole et al.|EClinicalMedicine|2024Cited by 23